Allotment of shares pursuant to Scheme of Amalgamation of Solvay Pharma India Ltd with the Company
Abbott India Ltd has informed BSE that the Committee of Directors appointed for purpose of allotment of shares has at its meeting held September 07, 2011 allotted 75,74,062 equity shares of Rs. 10 each of the Company to the shareholders of Solvay Pharma India Ltd in the ratio of 2:3, in terms of the Scheme of Amalgamation of olvay Pharma India Ltd with the Company.... Updates
Abbott India Ltd has informed BSE that it has fixed August 29, 2011 as the Record Date for the purpose of determining the entitlement of shareholders of Solvay Pharma India Ltd, who will be allotted shares of Abbott India Ltd, in terms of the Share Swap Ratio of 2:3. Revised Financial Results for Jun 30, 2011
Abbott India Ltd has informed BSE about the Revised Financial Results for the Period ended June 30, 2011. Financial Results for Jun 30, 2011
Abbott India Ltd has informed BSE about the Financial Results for the Period ended June 30, 2011. Updates on Scheme of Amalgamation
Abbott India Ltd has informed BSE that the Order passed by the Hon'ble High Court of Bombay sanctioning the Scheme of Amalgamation of Solvay Pharma India Ltd with Abbott India Ltd has been filed with the Registrar ofCompanies, Maharashtra today i.e. August 10, 2011. High Court approval on Scheme of Amalgamation
Abbott India Ltd has informed BSE that the Hon'ble High Court of Bombay, on July 15, 2011, has sanctioned the Scheme of Amalgamation of Solvay Pharma India Limited, the Transferor Company with Abbott India Limited, the Transferee Company. Updates on Outcome of AGM
Abbott India Ltd has submitted to BSE a copy of the minutes of the 67th Annual General Meeting of the Company held on April 27, 2011. (For more details kindly refer Corporate Announcements on www.bseindia.com). Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Abbott India Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE Updates
Abbott India Ltd has informed BSE that:"On May 17, 2011 Abbott Capital India Limited sold 224000 of the 9428184 shares held by it in Abbott India Limited by way of an on market transaction. As a consequence, the promoter shareholding in Abbott India Limited after the merger of Solvay Pharma India Limited into Abbott India Limited will be 74.98%. Therefore, the listing of shares issued pursuant to the share exchange ratio in the merger will... Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Reliance Capital Asset Management Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE